Inspire Medical Systems, Inc. 2025 Q4 - Results - Earnings Call Presentation

Inspire Medical Systems released its Q4 2025 earnings presentation, detailing financial performance and operational updates during its February 2026 earnings call. Revenue growth and key metrics were highlighted, reflecting the company’s expanding market penetration in sleep apnea treatments through its neurostimulation technology. The presentation emphasized clinical trial progress, including FDA-related milestones and regulatory approvals that could accelerate commercial adoption of its flagship device. Operational expansions, such as new manufacturing facilities or partnerships, were outlined to support scaling production amid rising demand for minimally invasive sleep therapy solutions. Investor guidance for 2026 was provided, projecting continued growth driven by innovation, reimbursement expansions, and global market strategies.